Aripiprazole — Drug Intelligence | 12 EU Trials

Filter these 12 trials by condition, phase, country and more.

Open in Search →

12 Registered trials

7 Recruiting

3 Completed trials

12 Sponsors

7 Countries

Phase III

Phase II

Phase IV

Phase III: 2 Phase II/III: 1 Phase II: 2 Phase IV: 6 Phase I (Other): 1

Indications tested

Abnormal behaviour 1 Schizophrenia 1 Schizoaffective disorder 1 Psychotic disorder 1 Anxiety disorder 1 Schizophreniform disorder 1

Sponsors using this IMP

Consorcio Centro De Investigacion Biomedica En Red 1 Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC) 1 Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico 1 Fundacion Para La Gestion De La Investigacion En Salud De Sevilla 1 Fundacion Publica Andaluza Para La Gestion De La Investigacion En Salud De Sevilla 1 Hospices Civils De Lyon 1 Les Hopitaux Universitaires De Strasbourg 1 Parnassia Groep B.V. 1 Region Hovedstadens Psykiatriske 1 Stichting GGZ Drenthe 1 Universitair Medisch Centrum Groningen 1 Universitair Medisch Centrum Utrecht 1

All trials

12 total

A prospective, randomized, and controlled study comparing two treatment strategies (Dose REduction of Antipsychotics vs. Maintenance treatme… Pending

2023-509558-80-00 Phase III 1 country Les Hopitaux Universitaires De Strasbourg
EPABID: Efficacy of Pipamperone and Aripiprazole on Behaviors that challenge in Intellectual Disabilities Pending

2024-519833-51-00 Phase IV 1 country Stichting GGZ Drenthe
Clinical trial to study the effect of an already authorized drug on other pathologies by administering it to people with a recent diagnosis … Recruiting

2024-519778-38-00 Phase II/III 1 country Fundacion Para La Gestion De La Investigacion En Salud De Sevilla
A randomised, controlled trial to investigate the effect of a six-week intensified pharmacological treatment for schizophrenia compared to t… Recruiting

2023-506602-39-00 Phase IV 4 countries Universitair Medisch Centrum Utrecht
Safety and pharmacokinetics of antipsychotics in children 2: Studying TDM in an RCT Recruiting

2024-511568-96-00 Phase IV 2 countries Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)
Comparison of esketamine with an antidepressant versus aripiprazole with an antidepressant, in the refractory major depression disorder in e… Recruiting

2024-512672-34-00 Phase III 1 country Fundacion Publica Andaluza Para La Gestion De La Investigacion En Salud De Sevil…
A New Intervention for Implementation of Pharmacogenetics in Psychiatry Recruiting

2023-509680-25-00 Phase IV 3 countries Parnassia Groep B.V.
Multidisciplinary Design to Optimize Schizophrenia Treatment Based on Multi-omics Data and Systems Biology Analysis (SchizOMICS) Recruiting

2024-516768-28-00 Phase IV 1 country Consorcio Centro De Investigacion Biomedica En Red
Involvement of the serotonergic system in the control of impulsivity in Tourette disorder : ARITEP Recruiting

2023-506370-13-00 Phase II 1 country Hospices Civils De Lyon
HAMLETT. Handling Antipsychotic Medication: Long-term Evaluation of Targeted Treatment. A study comparing continuation versus discontinuatio… Ended

2024-518769-80-00 Phase IV 1 country Universitair Medisch Centrum Groningen
AMEND - Add-on MEmaNtine to Dopamine modulation to improve negative symptoms at first psychosis Ended

2024-513878-21-02 Phase I (Other) 1 country Region Hovedstadens Psykiatriske
Cannabidiol as an Add-on Treatment to substance abuse in juvenile patients with PSYchosis: a double-blind randomized placebo-controlled stud… Ended

2024-514393-44-00 Phase II 1 country Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico

Showing 1–12 of 12 trials

← All drugs A–Z